Genetic variants in sporadic parkinson's disease: East vs west

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Peeraully, Tasneem ^a   Tan, E K ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

East vs West; Gene variant; Parkinson's disease

Indexed keywords

CARRIER PROTEIN; N ETHYLMALEIMIDE SENSITIVE FACTOR; PROTEIN SLC25A48; PROTEIN SLCO3A1; SCAVENGER RECEPTOR B; SCAVENGER RECEPTOR B2; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG; WNT3 PROTEIN;

ARTICLE; BDNF GENE; BST1 GENE; CHROMOSOME 1Q; ETHNIC DIFFERENCE; FAMILIAL DISEASE; GAK GENE; GENE; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GRIN2A GENE; HAPLOTYPE; HLA DRB5 GENE; HUMAN; LRRK8 GENE; MAPT GENE; NEUROPATHOLOGY; PARK16 GENE; PARKINSON DISEASE; PINK1 GENE; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STK39 GENE;

EID: 84858693962     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70021-9     Document Type: Article

References (21)

1. Schulte C, Gasser T. Genetic basis of Parkinson's disease: inheritance, penetrance, and expression. Appl Clin Genet 2011;4:67-80.
2. Haugarvoll K, Wszolek ZK. Clinical features of LRRK2 parkinsonism. Parkinsonism Relat Disord 2009;15(Suppl 3):S205-8.
3. Bardien S, Lesage S, Brice A, Carr J. Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease. Parkinsonism Relat Disord 2011 Aug;17(7):501-8.
4. Biernacka JM, Armasu SM, Cunningham JM, Ahlskog JE, Chung SJ, Maraganore DM. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility? Parkinsonism Relat Disord 2011 Aug 2 [Epub ahead of print]. doi: 10.1016/j.parkreldis.2011.07.001.
5. Johansen KK, White LR, Farrer MJ, Aasly JO. Subclinical signs in LRRK2 mutation carriers. Parkinsonism Relat Disord 2011;17(7):528-32.
6. Johansen KK, Hasselberg K, White LR, Farrer MJ, Aasly JO. Genealogical studies in LRRK2-associated Parkinson's disease in central Norway. Parkinsonism Relat Disord 2010;16(8):527-30.
7. Kiyohara C, Miyake Y, Koyanagi M; Fukuoka Kinki Parkinson's Disease Study Group. GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson's disease in a Japanese population. Parkinsonism Relat Disord 2010;16(7):447-52.
8. Lu CS, Simons EJ, Wu-Chou YH, Fonzo AD, Chang HC, Chen RS, et al. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease. Parkinsonism Relat Disord 2005;11:521-2.
9. Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohé CF, et al. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 2006;7(3):133-8.
10. Tan EK, Peng R, Teo YY, Tan LC, Angeles D, Ho P, et al. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat 2010;31(5):561-8.
11. Farrer MJ, Stone JT, Lin CH, Dächsel JC, Hulihan MM, Haugarvoll K, et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 2007;13(2):89-92.
12. Lin CH, Wu RM, Tai CH, Chen ML, Hu FC. Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson's disease. Parkinsonism Relat Disord 2011;17(2):84-8.
13. Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, et al. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 2011 Aug 30 [Epub ahead of print]. doi: 10.1016/S1474-4422(11)70175-2.
14. Skipper L, Li Y, Bonnard C, Pavanni R, Yih Y, Chua E, et al. Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. Hum Mol Genet 2005;14(23): 3549-56.
15. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009;41(12):1303-7.
16. Tan EK, Kwok HH, Tan LC, Zhao WT, Prakash KM, Au WL, et al. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. Neurology 2010;75(6):508-12.
17. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, et al. Genomewide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009;41(12):1308-12.
18. International Parkinson Disease Genomics Consortium, Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011;377(9766):641-9.
19. Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, Kay DM, et al. Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet 2011;7(8):e1002237.
20. Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010;42(9):781-5.
21. Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, et al. Webbased genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 2011;7(6):e1002141.